Many investors focus on the dividend yield, but not much on the dividend growth.
Buy Aflac for its high-interest rate sensitivity, superior financial strength, and best-in-class capital return strategy amid a steepening yield curve. Aflac's dominant Japan exposure, iconic brand, low debt/equity, and consistent dividend growth set it apart from peers like MetLife and Prudential. AFL offers a compelling 2.5x risk/reward to a $120 target (vs. $102 stop), supported by historical outperformance and a temporary slowdown in price momentum.
I am downgrading AFL to a hold due to slowing revenue and earnings growth and a premium valuation versus peers. AFL's Q2 results showed declining revenue and EPS, with investment losses and Japan segment weakness offsetting US segment growth. Despite a strong balance sheet and impressive dividend growth history, current valuation metrics limit near-term upside potential.
Aflac (AFL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
AFL boosts its buyback plan to 130.9M shares as strong sales in Japan and higher U.S. margins fuel shareholder returns.
AFL's Q2 earnings benefit from robust Japan cancer insurance sales and strong persistency rates in the U.S. business, partly offset by rising costs.
Aflac Incorporated (NYSE:AFL ) Q2 2025 Earnings Call August 6, 2025 8:00 AM ET Company Participants Daniel Paul Amos - Chairman & CEO David Young - Corporate Participant Koichiro Yoshizumi - Senior Managing Exec. Officer and Asst.
While the top- and bottom-line numbers for Aflac (AFL) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Aflac (AFL) came out with quarterly earnings of $1.78 per share, beating the Zacks Consensus Estimate of $1.71 per share. This compares to earnings of $1.83 per share a year ago.
Health and life insurer Aflac on Tuesday beat Wall Street estimates for second quarter profit, driven by steady premium gains in the United States offset investment losses.
Here, we take a look at four insurance stocks, AFL, LMND, HRTG and AIZ, which are set to report second-quarter earnings on Aug. 5.
AFL braces for Q2 results with EPS likely to decline 6.6% and revenue off 13.7% as U.S. and Japan earnings face pressure.